
GSK, Amgen and AstraZeneca tout Phase 3 data in inflammatory nasal condition
GSK, Amgen and AstraZeneca released positive data supporting their rival drugs in a condition called chronic rhinosinusitis with nasal polyps, or CRSwNP. GSK’s depemokimab and … Sign up to read this article for free. Get free access to a …